Skip to main content

Table 1 Demographic, clinical characteristics, baseline bone turnover markers, biochemistry, and outcomes by bone mineral density assessments at 2-year follow-up

From: The association of time and medications with changes in bone mineral density in the 2 years after critical illness

Variable

All (n = 92)

Completed three BMD assessments (n = 48)

Completed one to two BMD assessments (n = 44)

p value

Age (yrs)

63.4 (±14.7)

65.8 (±11.4)

60.8 (±17.4)

0.1

BMI

27.1 (±5.1)

27.2 (4.4)

27.1 (5.8)

0.9

Women

44 (47.8)

22 (45.8)

22 (50.0)

0.8

Any osteoporosis risk factor

40 (43.5)

15 (31.3)

25 (56.8)

0.02

Co-morbidity

 Renal

7 (7.6)

4 (8.3)

3 (6.8)

1.0

 Cardiovascular

40 (43.5)

22 (45.8)

18 (40.9)

0.7

 Respiratory

22 (23.9)

8 (16.7)

14 (31.8)

0.1

APACHE III score

74.4 (±29.5)

76.3 (±29.3)

72.4 (±30.0)

0.5

ICU admission category

 Medical

54 (58.7)

26 (54.2)

28 (63.6)

 

 Cardiothoracic surgery

16 (17.4)

10 (20.8)

6 (13.6)

 

 General surgery

22 (23.9)

12 (25.0)

10 (22.7)

 

ICU biochemistry and biomarkers

 Albumin (g/L)

23.9 (±5.8)

23.6 (±5.9)

24.1 (±5.7)

0.6

 Calcium adj (mmol/L)

1.99 (±0.33)

2.01 (±0.32)

1.96 (±0.33)

0.5

 Creatinine (umol/L)

116 [85, 178]

125 [85, 175]

109 [89, 196]

0.7

 Vitamin D (nmol/L)

44.2 (±20.2)

43.4 (±20.0)

45.1 (±20.7)

0.7

 Phosphate (mmol/L)

0.70 [0.52, 1.00]

0.67 [0.49, 1.04]

0.72 [0.52, 0.96]

0.7

 PTH (pmol/L)

9.29 (±7.51)

9.88 (±7.94)

8.65 (±7.05)

0.4

 CTX (ng/L)

581 [400, 851]

581 [386, 884]

581 [414, 837]

1.0

 P1NP (ug/L)

31.5 [22.0, 60.0]

30.5 [22.0, 46.0]

32.5 [22.5, 87.0]

0.2

Hospital interventions/outcomes

 Ventilation duration (hrs)

86.0 [47.4, 146.0]

80.4 [43.9, 118.0]

91.9 [52.3, 215.0]

0.1

 Glucocorticoid

29 (31.5)

16 (33.3)

13 (29.5)

0.8

 CRRT

15 (16.3)

6 (12.5)

9 (20.5)

0.3

 ICU LOS (days)

6 [4, 9]

7 [4, 8]

6 [4, 11]

0.9

 Hospital LOS (days)

16 [11, 30]

15 [11, 28]

17 [10, 32]

0.7

Baseline BMD (post-ICU discharge)

 ICU admit to BMD (days)

33 [13,58]

36 [14, 63]

33 [12,56]

 

 T-score femur

-0.8 (±1.5)

-1.0 (±1.4)

-0.7 (±1.5)

0.3

 Absolute femur (g/cm3)

0.956 (±0.197)

0.941 (±0.183)

0.974 (±0.212)

0.4

 T-score AP spine

0.1 [-1.4, 1.0]

-0.1 [-1.6, 0.8]

0.1 [-1.3, 1.2]

0.4

 Absolute AP spine (g/cm3)

1.207 (±0.242)

1.200 (±0.228)

1.210 (±0.261)

0.7

Mortality

 1-year

8 (8.7)

0 (0)

8 (18.2)

 

 2-year

10 (10.9)

0 (0)

10 (22.7)

 
  1. Data are shown as mean (±standard deviation), median [interquartile range] or number (%). Complete BMD follow-up defined as all three post-ICU measurements performed during the 2-year period. Incomplete BMD follow-up defined as one or two post-ICU measurements performed. Reference ranges: vitamin D (<25 nmol/L = deficient, 25–50 nmol/L insufficient, >50 nmol/L sufficient), PTH (range 1.6–6.9 pmol)
  2. Abbreviations: BMD bone mineral density, BMI body mass index, APACHE Acute Physiology and Chronic Health Evaluation, ICU intensive care unit, PTH parathyroid hormone, CTX collagen type 1 cross-linked c-telopeptide, P1NP type 1 N-terminal procollagen, CRRT continuous renal replacement therapy, LOS length of stay, AP anterioposterior